AU Patent

AU2018200402B2 — Abuse-resistant mucoadhesive devices for delivery of buprenorphine

Assigned to Biodelivery Sciences International Inc · Expires 2019-04-18 · 7y expired

What this patent protects

The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing layer, and the pH in each layer is selected, such that absorption of buprenorphine is maximized.

USPTO Abstract

The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing layer, and the pH in each layer is selected, such that absorption of buprenorphine is maximized.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018200402B2
Jurisdiction
AU
Classification
—
Expires
2019-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Biodelivery Sciences International Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.